Merit predicts better than expected results:
This article was originally published in Clinica
Executive Summary
Merit Medical Systems, which makes disposable products for use in cardiology and radiology, says its third-quarter results will exceed previous guidance. The South Jordan, Utah company has already exceeded earnings guidance of $0.12 per share in the first two months of the quarter. The third quarter is traditionally its slowest in terms of revenue growth, the company says. "Our business is somewhat resilient to the economic and trying times we are experiencing and continues to be strong," said Fred Lampropoulos, Merit's president. The company also expects a strong fourth quarter, owing to distribution agreements, new product introductions and continued growth in existing product lines.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.